• 南宫NG·28(中国)相信品牌力量

    Endavastec

    Stock Code

    688016.SH

    Recently, MicroPort's Hercules™-B Bifurcated Stent-graft and its delivery system were honored with 2013 National Key New Project. It is the 5th consecutive years in which MicroPort has receive the certificate.


    Hercules™-B Bifurcated Stent-graft and the delivery system are indicated for endovascular treatment of abdominal aortic aneurysm. The applicable indications and ranges include the infrarenal AAAs in which the landing zone is more than 15mm. Hercules™-B Bifurcated Stent-graft is the second generation of AAA (abdominal aortic aneurysm) stent which is based on the technology of first generation product: Aegis. The improved stent structure, performance and the delivery system combined with full range of product specifications provide physicians and doctors with even more choices.


    Hercules™-B Bifurcated Stent-graft system consists of two major components: the main body (aorto-iliac bifurcated component) and a contralateral limb. During the surgery, those two components are being delivered separately into the human body through respective bilateral femoral artery and being connected as a whole at the lesion area. The deployment of bifurcated stent graft serves as an artificial vessel wall. It is a specially woven fabric tube (graft) supported by flexible wire frame (stent) that physicians use to create a new path for blood flow in the patient's aorta, reducing pressure on the aneurysm and the risk of rupture.


    "Currently, MicroPort's Hercules™-B Bifurcated Stent-graft system has about 15% of domestic market share in the field and it is being exported to various countries including Philippines, Argentina, Brazil and others." Ms. Zhenghua Miao, General Manager of MicroPort Endovascular (Shanghai) Co., Ltd. said, "In addition to the conventional similar products, Hercules™-B provides ease of access with its low profile, hydrophilic delivery system and anti-leakage structure to better accommodate a broad range of aortic anatomies, empowering physicians to offer endovascular aortic repair (EVAR) to more AAA patients than ever before."


    The National Key New Project refers to those that are developed for the first time in China or the innovative products that have outstanding performance among the similar products. Products recognized by the program generally have significant improvement in structure, material or technology compared with old products, and remarkably improve the product performance or extend functions. It's an important recognition from the government and milestone achievement for the company.

    友情链接: